Elevated D-Dimer Levels Predict a Poor Outcome in Critically Ill Patients

D-dimer is a biomarker of thrombosis and recently been considered to predict a poor outcome in patients with infectious diseases. Plasma D-dimer levels were measured in critically ill patients to examine their relationship with the poor outcome. The plasma D-dimer levels were markedly higher in the...

Full description

Bibliographic Details
Main Authors: Yuhuko Ichkawa Ms, Hideo Wada MD, PhD, Minoru Ezaki Mr, Motoko Tanaka, Shinya Hiromori, Katsuya Shiraki MD, PhD, Isao Moritani MD, PhD, Akitaka Yamamoto MD, PhD, Haruhiko Tashiro MD, PhD, Hideto Shimpo MD, PhD, Motomu Shimaoka
Format: Article
Language:English
Published: SAGE Publishing 2020-12-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/1076029620973084
Description
Summary:D-dimer is a biomarker of thrombosis and recently been considered to predict a poor outcome in patients with infectious diseases. Plasma D-dimer levels were measured in critically ill patients to examine their relationship with the poor outcome. The plasma D-dimer levels were markedly higher in the patients with various underlying disease especially venous thromboembolism in comparison to those without severe underlying diseases. The plasma D-dimer levels in non-survivors were significantly higher than those in survivors. In a receiver operating characteristic analysis, the area under the curve was high for the disseminated intravascular coagulation (DIC) score, the D-dimer value, and the prothrombin time-international normalize ratio (PT-INR). Adequate cut-off values for predicting the outcome were 3 as follows: DIC score, 3 points; D-dimer, 4.2 mg/L; and PT-INR, 1.08. D-dimer, which is a biomarker for thrombosis, is increased in various underlying diseases and predicts a poor outcome.
ISSN:1938-2723